Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu Qiu

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Cell Discovery|March 26, 2021
Immune memory in convalescent patients with asymptomatic or mild COVID-19Quan-Xin Long, Yan-Jun Jia, Xin Wang, et al.
Chinese Medical Journal|November 12, 2020
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasisLin Cai, Gen-Hui Chen, Qian-Jin Lu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing-Yi Li, Bin Yang, et al.
Nature Medicine|May 1, 2020
Antibody responses to SARS-CoV-2 in patients with COVID-19Quan-Xin Long, Bai-Zhong Liu, Hai-Jun Deng, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Cell Discovery|March 26, 2021
Immune memory in convalescent patients with asymptomatic or mild COVID-19Quan-Xin Long, Yan-Jun Jia, Xin Wang, et al.
Chinese Medical Journal|November 12, 2020
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasisLin Cai, Gen-Hui Chen, Qian-Jin Lu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing-Yi Li, Bin Yang, et al.
Nature Medicine|May 1, 2020
Antibody responses to SARS-CoV-2 in patients with COVID-19Quan-Xin Long, Bai-Zhong Liu, Hai-Jun Deng, et al.
Pageof 10